HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals › Research Explorer

Documents

thelancethiv-D-20-00332_R2_AMC
Accepted author manuscript, 0.99 MB, PDF document

DOI

https://doi.org/10.1016/S2352-3018(20)30301-5
Final published version

Original language	English
Pages (from-to)	e96-e105
Journal	Lancet HIV
Volume	8
Issue number	2
Early online date	2021
DOIs	https://doi.org/10.1016/S2352-3018(20)30301-5
Publication status	Published - Feb 2021

ID: 15136575